PDEX
Pro-Dex, Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
14.87
PEG
0.22
P/B
4.03
P/S
2.34
EV/EBITDA
9.93
DCF Value
$178.72
FCF Yield
3.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
28.3%
Operating Margin
15.7%
Net Margin
15.7%
ROE
29.2%
ROA
18.2%
ROIC
15.9%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $18.7M | $2.2M | $0.66 |
| Q1 2026 | $18.5M | $4.7M | $1.40 |
| Q4 2025 | $17.5M | $1.2M | $0.36 |
| FY 2025 | $66.6M | $9.0M | $2.67 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
-0.11
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.